Aurigene Pharmaceutical Services Limited (Aurigene), a contract research, development and manufacturing services organization and a step-down subsidiary of Dr. Reddy's Laboratories, announced the construction of a development and manufacturing facility for therapeutic proteins, antibodies and viral vectors.
As a first step in its investment plan, Aurigene is investing $40 million in a research and development (R&D) and pilot scale facility at Genome Valley, a well-known Biotechnology